Literature DB >> 12423153

Lobocyclamides A-C, lipopeptides from a cryptic cyanobacterial mat containing Lyngbya confervoides.

John B MacMillan1, Michael A Ernst-Russell, Jeffrey S de Ropp, Tadeusz F Molinski.   

Abstract

The structures of lipopeptides lobocyclamides A (1), B (2), and C (3) were solved using a combination of mass spectrometry, 2D NMR spectroscopy, and degradative analysis. Lobocyclamides B and C are the first peptides reported with the unusual amino acid 4-hydroxythreonine and also incorporate the rare homologous long-chain beta-amino acids 3-aminooctanoic acid and 3-aminodecanoic acid, respectively. The absolute configurations of the amino acid residues in each compound were assigned, after acid hydrolysis, by either direct chiral HPLC comparison with authentic standards or by prior derivatization by Marfey's method and reversed-phase HPLC. Both compounds exhibited moderate antifungal activity against a panel of Candida spp., including two fluconazole-resistant strains. When tested as a mixture, lobocyclamides A and B displayed synergistic in vitro antifungal activity, a phenomenon noted earlier for the related peptides laxaphycins A and B.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423153     DOI: 10.1021/jo0261909

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  24 in total

1.  Trichormamides C and D, antiproliferative cyclic lipopeptides from the cultured freshwater cyanobacterium cf. Oscillatoria sp. UIC 10045.

Authors:  Shangwen Luo; Hahk-Soo Kang; Aleksej Krunic; Wei-Lun Chen; Jilai Yang; John L Woodard; James R Fuchs; Sang Hyun Cho; Scott G Franzblau; Steven M Swanson; Jimmy Orjala
Journal:  Bioorg Med Chem       Date:  2015-05-01       Impact factor: 3.641

2.  Symplocin A, a linear peptide from the Bahamian cyanobacterium Symploca sp. Configurational analysis of N,N-dimethylamino acids by chiral-phase HPLC of naphthacyl esters.

Authors:  Tadeusz F Molinski; Kirk A Reynolds; Brandon I Morinaka
Journal:  J Nat Prod       Date:  2012-02-23       Impact factor: 4.050

3.  Antifungal activity improved by coproduction of cyclodextrins and anabaenolysins in Cyanobacteria.

Authors:  Tania K Shishido; Jouni Jokela; Clara-Theresia Kolehmainen; David P Fewer; Matti Wahlsten; Hao Wang; Leo Rouhiainen; Ermanno Rizzi; Gianluca De Bellis; Perttu Permi; Kaarina Sivonen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-16       Impact factor: 11.205

Review 4.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

5.  Isolation and Characterization of Actinoramides A-C, Highly Modified Peptides from a Marine Streptomyces sp.

Authors:  Sang-Jip Nam; Christopher A Kauffman; Paul R Jensen; William Fenical
Journal:  Tetrahedron       Date:  2011-09-02       Impact factor: 2.457

6.  Minutissamides A-D, antiproliferative cyclic decapeptides from the cultured cyanobacterium Anabaena minutissima.

Authors:  Hahk-Soo Kang; Aleksej Krunic; Qi Shen; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2011-06-23       Impact factor: 4.050

7.  Minutissamides E-L, antiproliferative cyclic lipodecapeptides from the cultured freshwater cyanobacterium cf. Anabaena sp.

Authors:  Hahk-Soo Kang; Megan Sturdy; Aleksej Krunic; Hyunjung Kim; Qi Shen; Steven M Swanson; Jimmy Orjala
Journal:  Bioorg Med Chem       Date:  2012-08-22       Impact factor: 3.641

8.  In vitro antibacterial activity of laboratory grown culture of Spirulina platensis.

Authors:  P Kaushik; Abhishek Chauhan
Journal:  Indian J Microbiol       Date:  2009-03-25       Impact factor: 2.461

9.  Cyanobacteria, Lyngbya aestuarii and Aphanothece bullosa as antifungal and antileishmanial drug resources.

Authors:  Maheep Kumar; Manoj Kumar Tripathi; Akanksha Srivastava; Jalaj Kumar Gour; Rakesh Kumar Singh; Ragini Tilak; Ravi Kumar Asthana
Journal:  Asian Pac J Trop Biomed       Date:  2013-06

10.  Discovery of new A- and B-type laxaphycins with synergistic anticancer activity.

Authors:  Weijing Cai; Susan Matthew; Qi-Yin Chen; Valerie J Paul; Hendrik Luesch
Journal:  Bioorg Med Chem       Date:  2018-03-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.